PAPER Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK
SEARCH RESULTS
330913 RESULTS
PAPER Alvarez-Fischer D, Henze C, Strenzke C, Westrich J, Ferger B, Höglinger GU, Oertel WH, Hartmann A
Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
Exp Neurol. 2008 Mar;210(1):182-93. PubMed: 18053987PAPER Mash DC, Adi N, Duque L, Pablo J, Kumar M, Ervin FR
Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers.
Drug Alcohol Depend. 2008 Apr 1;94(1-3):246-50. PubMed: 18055133PAPER Horvath MC, Kovacs GG, Kovari V, Majtenyi K, Hurd YL, Keller E
Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age.
J Neurosci. 2007 Dec 5;27(49):13371-5. PubMed: 18057194PAPER Parker WD, Parks JK, Swerdlow RH
Complex I deficiency in Parkinson's disease frontal cortex.
Brain Res. 2008 Jan 16;1189:215-8. PubMed: 18061150PAPER Ahmad MF, Raman B, Ramakrishna T, Rao Ch
Effect of phosphorylation on alpha B-crystallin: differences in stability, subunit exchange and chaperone activity of homo and mixed oligomers of alpha B-crystallin and its phosphorylation-mimicking mutant.
J Mol Biol. 2008 Jan 25;375(4):1040-51. PubMed: 18061612PAPER Wang YM, Pu P, Le WD
ATP depletion is the major cause of MPP+ induced dopamine neuronal death and worm lethality in alpha-synuclein transgenic C. elegans.
Neurosci Bull. 2007 Nov;23(6):329-35. PubMed: 18064062PAPER Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Brain. 2008 Mar;131(Pt 3):642-50. Epub 2007 Dec 13 PubMed: 18079166PAPER Palecek E, Ostatná V, Masarík M, Bertoncini CW, Jovin TM
Changes in interfacial properties of alpha-synuclein preceding its aggregation.
Analyst. 2008 Jan;133(1):76-84. PubMed: 18087617PAPER Schapira AH
Mitochondria in the aetiology and pathogenesis of Parkinson's disease.
Lancet Neurol. 2008 Jan;7(1):97-109. PubMed: 18093566PAPER Ravenstijn PG, Merlini M, Hameetman M, Murray TK, Ward MA, Lewis H, Ball G, Mottart C, de Ville de Goyet C, Lemarchand T, van Belle K, O'Neill MJ, Danhof M, de Lange EC
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments.
J Pharmacol Toxicol Methods. 2008 Mar-Apr;57(2):114-30. PubMed: 18155613PAPER Ghosh JG, Houck SA, Clark JI
Interactive sequences in the molecular chaperone, human alphaB crystallin modulate the fibrillation of amyloidogenic proteins.
Int J Biochem Cell Biol. 2008;40(5):954-67. PubMed: 18162431PAPER Outeiro TF, Kazantsev A
Drug Targeting of alpha-Synuclein Oligomerization in Synucleinopathies.
Perspect Medicin Chem. 2008;2:41-9. PubMed: 19787096PAPER Theuns J, Van Broeckhoven C
alpha-Synuclein gene duplications in sporadic Parkinson disease.
Neurology. 2008 Jan 1;70(1):7-9. PubMed: 18166703PAPER Poewe W
Dysautonomia and cognitive dysfunction in Parkinson's disease.
Mov Disord. 2007 Sep;22 Suppl 17:S374-8. PubMed: 18175399Current Filters
No filters selected